Private Capital Advisors’s MacroGenics MGNX Stock Holding History

Private Capital Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,500	Closed	-$332K	–	104
2017 Q4	$332K	Buy	+17,500	New	+$327K	0.12%	88
2017 Q1	–	Sell	-40,500	Closed	-$828K	–	124
2016 Q4	$828K	Sell	40,500 -32,000	-44%	-$805K	0.28%	69
2016 Q3	$2.17M	Buy	+72,500	New	+$2.16M	0.77%	40
2015 Q4	–	Sell	-61,415	Closed	-$1.32M	–	107
2015 Q3	$1.32M	Hold	61,415	–	–	0.55%	54
2015 Q2	$2.33M	Sell	61,415 -56,500	-48%	-$1.86M	0.76%	49
2015 Q1	$3.7M	Buy	117,915 +19,900	+20%	+$674K	1.35%	33
2014 Q4	$3.44M	Sell	98,015 -274,483	-74%	-$6.84M	1.29%	35
2014 Q3	$7.79M	Buy	372,498 +40,712	+12%	+$842K	2.52%	4
2014 Q2	$7.21M	Buy	+331,786	New	+$6.97M	2.33%	4

Other funds holding MGNX

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Private Capital Advisors's MGNX Position: Q1 2018 in Review

Private Capital Advisors sold out of MacroGenics (MGNX) in Q1 2018, closing a stake of 17,500 shares — an estimated $332K sold.

Private Capital Advisors first reported a position in MGNX in Q2 2014 and held it in 9 quarters. The position peaked at $7.79M in Q3 2014. 132 funds tracked by Wall St. Rank hold MGNX as of Q1 2018.

Private Capital Advisors reported no remaining MacroGenics position as of Q1 2018 after selling out during the quarter.
Private Capital Advisors sold 17,500 MacroGenics shares in Q1 2018, an estimated $332K.
Private Capital Advisors first reported a position in MacroGenics in Q2 2014 and held it in 9 quarters.
Private Capital Advisors's MacroGenics position peaked at $7.79M in Q3 2014.
132 funds tracked by Wall St. Rank held MacroGenics as of Q1 2018.

Based on Private Capital Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.